Literature DB >> 25850682

Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis.

Claudio Fozza1, Simonetta Pardini1, Domenica Barbara Giannico1, Clara Targhetta2, Anna Angela Di Tucci2, Paolo Dessalvi2, Emanuele Angelucci2, Fausto Dore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25850682     DOI： 10.1002/ajh.24030

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Promising Response to Thalidomide in Symptomatic β-Thalassemia.

Authors:  Ahmed K Yassin
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-18       Impact factor: 0.900

2.  Alternative Strategies in Thalassemia: Focus on Thalidomide.

Authors:  R Naithani; P Jeyaraman; M Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-05       Impact factor: 0.900

3.  Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.

Authors:  Jiang-Ming Chen; Wei-Jian Zhu; Jie Liu; Gui-Zhen Wang; Xiao-Qin Chen; Yun Tan; Wei-Wei Xu; Li-Wei Qu; Jin-Yan Li; Huan-Ju Yang; Lan Huang; Ning Cai; Wei-Da Wang; Ken Huang; Jian-Quan Xu; Guo-Hui Li; Sheng He; Tian-Ying Luo; Yi Huang; Song-Hua Liu; Wen-Qiang Wu; Qi-Yang Lu; Mei-Guang Zhou; Shu-Ying Chen; Rong-Lan Li; Mei-Ling Hu; Ying Huang; Jin-Hua Wei; Jun-Min Li; Sai-Juan Chen; Guang-Biao Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-11-18

4.  Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.

Authors:  Kun Yang; Yi Wu; Yali Zhou; Binbin Long; Qian Lu; Tianhong Zhou; Li Wang; Zhili Geng; Xiaolin Yin
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.